cytokines are responsible for the development as well as progression of this pathological condition. Several evidences suggest that cytokines play a crucial role in ovulation, implantation, placentation, and parturition during pregnancy. 2 They are the key mediators of several immunological cell signaling pathways. They are synthesized by both T helper 1 (Th1)-type and T helper 2 (Th2)-type immunity cells and exert both positive and negative effects in pregnancy. 3 They help in placental invasion, proliferation, and angiogenesis 4, 5 and can be classified as pro-and anti-inflammatory cytokines. Both types of cytokines are secreted by immune as well as non-immune cells like stromal and trophoblastic cells of the placenta, maternal deciduas, endothelial cells of mother, and fetus. 6 Their regulatory synthesis is required for various intracellular interactions that are crucial for the normal functioning of maternal and fetal immune system. Any modulation in the amalgation of these may adversely affect the functions of the immune competent cells. In addition, they are also responsible for the changes in the homeostasis of immune system and its functional disruption. The attenuation in the cytokine profile has been observed in many placental disorders like hypertension, preeclampsia, and eclampsia. 7, 8 Several researchers had noticed the imbalanced concentration of pro-and anti-inflammatory cytokines in preeclamptic placenta resulting enhanced trophoblastic apoptosis, intrauterine growth retardation or even may lead to preterm delivery. 9, 10 Moreover, the exemplified activation of pro-inflammatory cytokines in preeclamptic pregnant women leads to the development of systemic and local level inflammatory responses. 11 Substantial evidences showed the elevated levels of pro-inflammatory cytokines in the blood of preeclamptic women. 12 Despite of these investigations, the data available on these cytokines are controversial and their scrupulous role in the etiology of preeclampsia is not clear. Moreover, it is not clear whether the individual cytokine concentration or their ratio is responsible for the pathophysiology of preeclampsia. Therefore, the aim of the present study was to examine the expression of pro-inflammatory (IL-6, TNF-α) and anti-inflammatory (IL-4, IL-10) cytokines in preeclamptic placental tissues as well as in the serum of preeclamptic pregnant women from 28 weeks of gestation till term in the Indian population. In addition, attempts had been made to find an association among them.
| MATERIAL AND ME THODOLOGY

| Sample
For the present study, placental tissue and serum samples of preeclamptic as well as normal pregnant women were collected from the Department of Obstetrics and Gynaecology, Safdarjung Hospital, New Delhi, India. Ethical clearance from the institute and written informed consent from the patients were taken prior to collection. The inclusion criteria for the preeclamptic patients were hypertension (systolic BP > 140 mm Hg & diastolic BP > 90 mm Hg), proteinuria (>0.3 g/d), and edema after 20th week of gestation. The criteria for inclusion of controls were not having any history of pregnancy-related complications, diabetes or any other chronic medical illness, vaginal bleeding throughout pregnancy along with no evidence of congenital abnormalities, tuberculosis and not having habits like tobacco, alcohol, and smoking etc A total of 194 cases of preeclampsia and control were included in this study. The samples were then divided into two Groups that is, Group I (28-36 weeks) and II (37 weeks onwards) according to the gestational age. There were 55 placental tissue and serum samples in Group I of preeclampsia and control. The number of samples of preeclampsia and normal (placenta and serum) in Group II was 139 in total.
| Immunohistochemistry
The placental tissues of both Groups were fixed in 10% buffered formalin and embedded in paraffin. A tissue sections of 5µ thickness was processed for immunohistochemistry of pro-inflammatory (IL-6, TNF-α) and anti-inflammatory (IL-4, IL-10) cytokines. For the antigen 
| RT-PCR
| ELISA
The serum samples of both the Group I (N = 55) and Group II (N = 139) were quantitatively analyzed by sandwich enzyme-linked immunosorbent assay for pro-inflammatory (IL-6, TNF-α) and anti-inflammatory (IL-4, IL-10) cytokines. The protocol of ELISA kits (R&D Systems, Inc) was followed for the quantikine analysis of IL-6, TNF-α, IL-4, IL-10 (catalog no. D6050, DTA00C, D4050, and D1000B, respectively). The minimum detectable dose for IL-6, TNF-α, IL-4, IL-10 was typically <0.70 pg/mL, 0.5-5.5 pg/mL, 10 pg/mL, and 3.9 pg/mL, respectively.
| Scoring of immunohistochemical staining
The immunostained slides of both preeclampsia and control were arbitrarily chosen and blindly investigated by two observers. The slides were scored by following the criteria given by Rath et al 13 
cell). The intensity of the stained cells was categorized as "0": negative; "1": mild; "2" moderate; and "3": intense staining.
| Statistical analysis
The 
| RE SULTS
| Immunohistochemistry
The pro-inflammatory (IL-6, TNF-α) and anti-inflammatory (IL-4, IL-10) cytokines were localized in the cytoplasm of the syntiocytotrophoblast of placental tissues (Figure 1 ). The intensity of all the proteins was analyzed by calculating H-Score for each Group (I, II; Table 1 ).
The 313.17 ± 3.45; Figure 2E -H). These results suggest the improper expression prevailing in preeclampsia may be responsible for the pathophysiology of preeclampsia.
| RT-PCR
RT-PCR results were in concordance with IHC findings. The band intensity of IL-6 and TNF-α was increased in preeclamptic cases in comparison to control while IL-4 and IL-10 were downregulated in preeclampsia ( Figure 3) . The bands were quantified, and results are mentioned in Table 2 . TA B L E 1 H-Score assessment of IL-6, TNF-α, IL-4, and IL-10 in placental tissue of preeclampsia and control in Group I and II (mean ± standard deviation) 
Study
| ELISA
The serum concentration of IL-6 in Group I (mean ± SD = 22.68 pg/ mL ± 0.27) and Group II of preeclamptic women (mean ± SD = 26.03 pg/mL ± 0.71) was significantly higher than Group I (mean ± SD = 17.07 pg/mL ± 0.44) and Group II (mean ± SD = 16.12 pg/mL ± 0.33) of control ones (Table 3 , P = 0.0001). Hence, the concentration of IL-6 increases in preeclamptic maternal serum throughout gestation. The serum TNF-α was significantly upregulated in Group I (mean ± SD = 20.16 pg/mL ± 0.48) and Group II Table 3 , P = 0.0001). Thus, the serum concentration of TNF-α kept on increasing until the end of pregnancy during preeclampsia.
In preeclamptic Group, the mean serum concentration of IL-4 was decreased in Group I (mean ± SD = 18.21 pg/mL ± 0.05) and
Group II (mean ± SD = 12.77 pg/mL ± 0.81). While in uncomplicated controls, the IL-4 concentration of Group I (mean ± SD = 25.69 pg/ mL ± 0.11) and II (mean ± SD = 29.25 pg/mL ± 0.34) were lesser than the preeclamptic cases ( Figure 4E ,F). The Group I and II of IL-10 showed specificity of 83.75%, 80.2%; sensitivity of 88.75%, 82.75% with area under curve of 0.925, 0.881, respectively, in preeclampsia than that of control (Table 4 , Figure 4G ,H).
The mean cut-off value for IL-6, TNF-α, IL-4, and IL-10 was 18.79, 19.28, 9.02, and 10.22 pg/mL in (Table 4 ). On the basis of cut-off values, it can be predicted that these proteins have the ability to distinguish the normal pregnant women from the preeclamptic ones.
| Inter-protein correlation
In preeclamptic placental tissues, Group I and II of IL-6 showed a Table S1 ).
In serum samples of preeclamptic mother, Group I, II of IL-6
were directly related to TNF-α (r = 0.711, P = 0.0001; r = 0.562, P = 0.0001) while it was inversely correlated with both Groups of IL-4 and IL-10 (r = −0.576, P = 0.0001, r = −0.411, P = 0.0001 and r = −0.669, P = 0.0001; r = −0.537, P = 0.0001, respectively).
Similarly, TNF-α was also negatively related with both Groups I of IL-4 and IL-10 (r = −0.519, P = 0.0001, r = −0.649, P = 0.0001 and r = −0.645, P = 0.0001; r = −0.584, P = 0.0001, respectively). While the IL-4 and IL-10 were directly related to each other Group I and II (r = 0.724, P = 0.0001; r = 0.865, P = 0.0001; Table S2 ).
Thus, our findings showed that throughout the pregnancy, these cytokines are intercorrelated with each other in both the placenta and serum of preeclamptic mother.
| D ISCUSS I ON
The pro-inflammatory cytokines (IL-6, TNFα) are important mediators of maternal immune system and are secreted in excess by maternal immune cells in preeclampsia. 14 The IL-6 and TNF-α cytokine affects the functioning of endothelial cells by increasing the vascular permeability and induces apoptosis of the trophoblastic cells. 15, 16 They activate as well as damage the endothelial cells to intricate the maternal inflammatory responses. These are also responsible for the pathophysiological characteristics of preeclampsia. 17 Several researchers have proved that IL-6 and TNF-α have the capability to induce preeclamptic symptoms in pregnant rats or baboons via activation of endothelium 18, 19 by activating the endothelin and TA B L E 3 The serum concentration (pg/mL) of IL-6, TNF-α, IL-4, and IL-10 in normal and preeclamptic cases in Group I and II (mean ± standard deviation) renin-angiotensin system. 20, 21 The synthesis of these cytokines is increased in preeclampsia and amends the levels of anti-inflammatory cytokines. [22] [23] [24] In the present study, the protein and mRNA levels of IL-6 and TNF-α were found to be significantly increased in the preeclamptic placental tissues than that of the control in Group I and II (P = 0.0001, P = 0.0001). In addition, our results also revealed that the levels of the cytokines increases from Group I to Group II and reaches maximum values. The ELISA analysis on the preeclamptic maternal serum showed that there was also a significant upregulation of these cytokines from Group I to II. Thus, the levels of pro-inflammatory cytokines kept on increasing from the 28 weeks of gestation till term in both placenta and serum of preeclamptic mother. The anti-inflammatory cytokines (IL-4, IL-10) are crucial for the functioning of T helper cell 2 (Th2) and regulatory T cells (Treg) 25, 26 for the successful progression of pregnancy. Any modulation in their level may affect the functioning of several immunological and apoptotic pathways leading to pregnancy-associated syndromes like preeclampsia. 27 Several experiments on mice had reported that the scarcity of IL-10 leads to inflammation. 28, 29 Hanna et al 30 examined that the levels of IL-10 were increased in the first and second trimester but decreases in the third trimester of normal pregnancy. But, in this study, the intensity of IL-4 and IL-10 was found to be decreased in both Groups of preeclamptic placental tissues while upregulated in control ones. In the maternal serum samples, their levels were also found to be decreased in preeclampsia than that of the control. From these observations, it may be presumed that in preeclampsia, IL-10
and IL-4 are not able to exert their regulatory effects on pro-inflammatory cytokines resulting aggravated inflammatory responses.
Several researchers had reported that the abnormal balance of these cytokines may be associated with the disruption of vascular system and preeclampsia. [31] [32] [33] In our investigations, the pro-and anti-inflammatory cytokines were strongly negatively correlated with each other in both placenta and serum of preeclamptic women in samples of the enrolled Groups I and II. There was a positive correlation between IL-4 and IL-10 as well as in between TNF-α and IL-6 in preeclampsia samples. The increased ratio of pro-to anti-inflammatory cytokines in preeclampsia, observed in this study, may suggest that decreased levels of IL-4 and IL-10 will accelerate the production of pro-inflammatory cytokines and exacerbate a Th-2 cytokine dominant stage resulting excessive inflammation. Therefore, a balance between the two is important to curtail the maternal inflammatory system after 28 weeks of pregnancy.
Thus, the modulation in individual cytokine level along with their amended ratio may be responsible for the progression of pathophysiological characteristics of preeclampsia in later phases of pregnancy.
From the present study, it may be concluded that the intensity of these inflammatory cytokines continuously modulates in both placenta and serum of preeclamptic mother immediately after the onset of preeclampsia. Their imbalanced levels cause activation of associated cellular signaling pathways like Toll-like receptor, NF-κB. [34] [35] [36] [37] The downstream targets of these pathways may further affect the placental immune-tolerance by impacting a negative effect on the placentation process, secretion of trophoblastic microvesicles, and endothelial cells disruption. This in turn, results in exemplified systemic inflammation leading to several adverse pregnancy outcomes like preeclampsia.
Hence, these studied cytokines can be used as biomarkers for the prediction and better clinical management of preeclampsia in the initial stages. Integrative studies revealing the molecular mechanism responsible for cellular communication between cytokines and signaling pathways are important to determine their exact effect on inflammation process. The new therapeutic strategies targeting the pool of these pro-and anti-inflammatory cytokines may be designed for the treatment of this disorder. Since all the cytokines function in a spatiotemporal manner, a large cohort study including several immune system cytokines may be warranted for better understanding of the immunological etiology and pathophysiology of preeclampsia.
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